![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07H 21/00 | (2006.01) |
C07H 21/02 | (2006.01) | ||
C07H 21/04 | (2006.01) | ||
C12N 15/63 | (2006.01) | ||
A61K 48/00 | (2006.01) | ||
A61K 39/39 | (2006.01) |
(11) | Number of the document | 1996238 |
(13) | Kind of document | T |
(96) | European patent application number | 07752109.4 |
Date of filing the European patent application | 2007-02-28 | |
(97) | Date of publication of the European application | 2008-12-03 |
(45) | Date of publication and mention of the grant of the patent | 2016-04-06 |
(46) | Date of publication of the claims translation | 2016-09-12 |
(86) | Number | PCT/US2007/005386 |
Date | 2007-02-28 |
(87) | Number | WO 2007/100908 |
Date | 2007-09-07 |
(30) | Number | Date | Country code |
778026 P | 2006-02-28 | US | |
801645 P | 2006-05-19 | US | |
802992 P | 2006-05-22 | US | |
821492 P | 2006-08-04 | US | |
846658 P | 2006-09-22 | US | |
848195 P | 2006-09-28 | US |
(72) |
TUCKER, Sean, N., US
|
(73) |
Vaxart, Inc.,
600 Townsend Street Suite 120E, San Francisco, CA 94103,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Chimeriniai adenovirusiniai vektoriai ir dsRNR, kaip TLR3 antagonistas |
Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist |
Payment date | Validity (years) | Amount | |
2020-01-31 | 14 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-02-28 |